Analysis of ORP2-knockout hepatocytes uncovers a novel function in actin cytoskeletal regulation by Kentala, Henriikka et al.
THE
JOURNAL • RESEARCH • www.fasebj.org
Analysis of ORP2-knockout hepatocytes uncovers a
novel function in actin cytoskeletal regulation
Henriikka Kentala,* Annika Koponen,* Annukka M. Kivela¨,* Robert Andrews,† ChunHei Li,†,‡ You Zhou,*,†,‡
and Vesa M. Olkkonen*,§,1
*Minerva Foundation Institute for Medical Research, Helsinki, Finland; †Systems Immunity Research Institute and ‡Division of Infection and
Immunity, Cardiff University School of Medicine, Cardiff University, Cardiff, United Kingdom; and §Department of Anatomy, Faculty of
Medicine, University of Helsinki, Finland
ABSTRACT:ORP2 is implicated in cholesterol transport, triglyceridemetabolism, andadrenocortical steroidhormone
production. We addressed ORP2 function in hepatocytes by generating ORP2-knockout (KO) HuH7 cells by
CRISPR-Cas9 gene editing, followed by analyses of transcriptome, F-actin morphology, migration, adhesion, and
proliferation. RNA sequencing ofORP2-KO cells revealed >2-fold changes in 579mRNAs. The Ingenuity Pathway
Analysis (IPA) uncovered alterations in the following functional categories: cellular movement, cell–cell signaling
and interaction, cellular development, cellular functionandmaintenance, cellulargrowthandproliferation, and cell
morphology. Many pathways in these categories involved actin cytoskeleton, cell migration, adhesion, or pro-
liferation. Analysis of theORP2 interactome uncovered 109 putative newpartners. Their IPA analysis revealedRas
homolog A (RhoA) signaling as the most significant pathway. Interactions of ORP2 with SEPT9, MLC12, and
ARHGAP12 were validated by independent assays. ORP2-KO resulted in abnormal F-actin morphology charac-
terized by impaired capacity to form lamellipodia, migration defect, and impaired adhesion and proliferation.
Rescue of the migration phenotype and generation of typical cell surface morphology required an intact ORP2
phosphoinositide binding site, suggesting that ORP2 function involves phosphoinositide binding and transport.
The results point at a novel function of ORP2 as a lipid-sensing regulator of the actin cytoskeleton, with impacts on
hepatocellularmigration, adhesion, andproliferation.—Kentala,H.,Koponen,A.,Kivela¨, A.M.,Andrews,R., Li,C.,
Zhou, Y., Olkkonen, V.M. Analysis of ORP2-knockout hepatocytes uncovers a novel function in actin cytoskeletal
regulation. FASEB J. 32, 1281–1295 (2018). www.fasebj.org
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Oxysterol binding protein (OSBP)–related proteins
(ORPs) are an evolutionarily conserved family of 12
mammalian lipid-binding proteins. OSBP/ORPs are
characterized as intracellular lipid transporters or
sensors with implications in various cellular processes,
including nonvesicular lipid transport, membrane traf-
ficking and cell signaling (1–3). ORP2 is ubiquitously
expressed (4), and the protein is readily detectable by
Western analysis in hepatoma cells such as HuH7, in
immortalized noncancerous human hepatocytes, and in
human liver tissue. Similar to most of the ORPs, ORP2 is
a cytosolic protein but also associates peripherally with
cell membranes. ORP2 lacks a membrane targeting the
phosphatidylinositol-phosphate (PIP)-sensing pleckstrin
homology (PH) domain found in theORPs.Nevertheless,
ORP2 targets the surface of the intracellular lipid droplets
(LDs) and, under specific ligand conditions, the plasma
membrane (5). It also associates with the endoplasmic
reticulum(ER)via theER trans-membraneproteinsVAMP-
associated protein A and B (VAP-A and -B). Via these dis-
tinct membrane interactions, ORP2 localizes at ER–LD
membrane contact sites (MCSs) (3). The ORP2–VAPMCS
tethering is reversible, however; treatment of cells with the
high-affinity ligand of ORP2, 22(R)-hydroxycholesterol
(OHC) (5) induces a translocation of ORP2–VAP-A com-
plexes from the LD surface (3).
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The cellular function of ORP2 has been suggested to
associate with cholesterol and triacylglycerol (TG)
homeostasis (5–7). Moreover, Escajadillo et al. (8) ob-
served that ORP2 knockdown in adrenocortical cells
down-regulated key enzymes of cortisol biosynthesis
and reduced the cellular concentrations of several
steroidmetabolites. The suppression of ORP2was also
found to increase the cellular level of cholesterol and
decrease 22(R)-OHC and 7KC. Sewer and colleagues
(9) reported a direct interaction betweenORP2 andRas
homolog (Rho)A effector protein diaphanous-related
formin (DIAPH)-1, a component involved in RhoA
signaling and with an important role in adrenocortical
steroid hormone production (10).
Besides the above observations linkingORP2 function to
cellular lipid homeostasis and synthesis of steroid hor-
mones, theproteinwas found to localize to the stereocilia of
cochlear inner andouterhair cells.Heterozygousmutations
in theOSBPL2 gene encodingORP2were reported to cause
anautosomaldominantnonsyndromichearing loss (11, 12).
The present study provides novel clues of the cellular
function of ORP2 beyond lipid metabolism. Identification
of ORP2 interaction partners and RNA sequencing of
ORP2-knockout (KO) hepatocytes suggest a connection
between ORP2 and actin cytoskeletal regulation via RhoA
signaling. Consistently, ORP2 knockout resulted in an
inhibition of cell adhesion, migration, and proliferation.
MATERIALS AND METHODS
Antibodies and other reagents
The rabbit anti-ORP2 antibody was described in Laitinen et al.
(4). Anti-b-actin and anti-cortactin were from Millipore-Sigma
(Billerica, MA, USA), and anti- Ras GTPase-activating-like pro-
tein (IQGAP)-1 and anti-green fluorescent protein (GFP) were
from BD Biosciences (San Jose, CA, USA). Oregon green
488 phalloidin and the fluorescent secondary antibody (Alexa
Fluor-594 goat anti-mouse) were from Thermo Fisher Scientific
(Waltham, MA, USA). Magnetic anti-hemagglutinin (HA)
beads were purchased from Thermo Fisher Scientific and anti-
V5 beads from MBL (Woburn, MA, USA). Latrunculin B,
Y27632, and insulin were from Millipore-Sigma.
cDNA constructs
HA epitope-tagged ORP2 was generated by inserting a dou-
ble HA tag in a BglII restriction site between the N-terminal
Venus fragment of ORP2 in VN-ORP2 (7). For overexpression
ofwild-typeORP2, the cDNAwas inserted between the BglII and
KpnI sites of the pmCherry-C1 vector (Takara Bio, Mountain
View, CA, USA). ORP2 mPIP (H178–179A, K423A) and mFFAT
(F7–8V,D9V)mutantshavebeendescribed inWeber-Boyvan et al.
(7) and were similarly inserted into pmCherry. For production of
recombinant glutathione S-transferase (GST)-ORP2 in Spodoptera
frugiperda Sf9 cells GST-ORP2 was PCR amplified from ORP2-
pGEX1lTplasmid (4) and cloned into pFastBac1 vector (obtained
fromBioMediTech Protein Technologies Core Facility) usingXhoI
and KpnI restriction sites. GFP fusion expression constructs of
SEPT9 and MLC12 were generated with the Gateway system
(Thermo Fisher Scientific) at the University of Helsinki Genome
Biology Unit (GBU). Likewise, ORP2 tagged at the C terminus
withV5epitopewasgeneratedbyusing theGatewaySystem.The
GFP- rho GTPase activating protein 12 (ARHGAP12) expression
constructwas obtained fromDr.Michael Courtney (University of
Turku, Turku, Finland).
Light and fluorescence microscopy
Bright-field microscopy images were acquired with the Evos XL
Cell Imaging System (AMG; Thermo Fisher Scientific). Fluores-
cence signals were detected with an Axio Observer Z1 micro-
scopewith an ECPlnN340 0.75 DICII or a PlnApo363/1.40 oil
DICII objective and Colibri laser (Zeiss, Oberkochen, Germany).
Images were recorded with the Zen 2 v.2.0.0 software (Zeiss).
Image panels were created with Adobe Photoshop 7 software
(San Jose, CA, USA).
Guide RNA constructs
The ORP2 protein was stably knocked out in HuH7 cells via
double RNA-guided clustered regularly interspaced short pal-
indromic repeats (CRISPR) with Cas9-nickase endonuclease ac-
tivity. Guide RNAs (gRNAs) to target the endogenous OSBPL2
were designedwith theCRISPRdesign tool (http://crispr.mit.edu/;
Massachusetts Institute of Technology, Cambridge, MA, USA)
with nickase analysis. The designed gRNAprimers are listed
in Table 1. The pGL3-puro-sgRNA (13, 14) (obtained from
Dr. Shiqian Li, Department of Anatomy, University of Helsinki)
vector was digested with BbsI and the annealed parallel gRNA
sense and antisense primerswere ligated into the vector with T4
ligase (New England Biolabs, Ipswich, MA, USA) according to
themanufacturer’s instructions. Plasmidswere transformed into
Escherichia coli DH5a (New England Biolabs) and verified by
sequencing.
Generation of stable ORP2-KO HuH7 cell lines
The HuH7 human hepatoma cell line (15) was cultured as de-
scribed in Kentala et al. (3). HuH7 cells were seeded into 12-well
plates and transfected using Lipofectamine 2000 (Thermo Fisher
TABLE 1. The OSBPL2-speciﬁc gRNA primers
OSBPL2 target
Sequence
Sense Antisense
Exon 4
Guide 4-A CACCGAAGTCGCTTCTGCTGAACAT AAACATGTTCAGCAGAAGCGACTTC
Guide 4-B CACCGACCATCCTGAAGAAGTGTGT AAACACACACTTCTTCAGGATGGTC
Exon 5
Guide 5-A CACCGAGAGGCTCGTTGAAGGCGAT AAACATCGCCTTCAACGAGCCTCTC
Guide 5-B CACCGCAGCGGATCACGGAGTACA AAACTGTACTCCGTGATCCGCTGC
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Scientific). Transfection mixtures contained 0.4 mg gRNA 5-A
and 0.4 mg gRNA guide 5-B or 0.2 mg gRNA guide 4-A, 0.2 mg
gRNA guide 4-B, 0.2 mg gRNA guide 5-A, and 0.2 mg gRNA
guide 5-B, combinedwith 1.2mgCas9n (13, 14) (pcDNA4-Cas9n-
2A-GFP, obtained from Dr. Shiqian Li) and 4 ml Lipofectamine
2000.Cas9 controlHuH7 cellswerepreparedwithout adding the
OSBPL2 specific gRNA constructs into the transfection mixture.
At 24h after transfection, the cellswere subjected to fluorescence-
activated cell sorting (FACSAriaII; BD Biosciences) at the Bio-
medicum Flow Cytometry Core Facility (Helsinki, Finland).
Single-cell cloneswerecultured for3wk togenerate stableORP2-
KO cell lines. The ORP2-KO cell lines are referred to herein as
ORP2-KO1 (for guide 5) and ORP2-KO2 (for guide 4+guide
5). The effectiveness of ORP2-KO was analyzed by Western
blot analysis with anti-ORP2 antibody. The defects gener-
ated were identified in ORP2 cDNA by amplifying the exon
4–5 region, cloning the PCR products, and sequencing in-
serts from each cell line.
Generation of recombinant lentiviruses
ORP2 cDNAs were subcloned into the Gateway entry vector
pENTR2B (Thermo Fisher Scientific). The constructs were
recombined into pLenti7.3/V5-DEST at the GBU (Helsinki Uni-
versity), and recombinant lentiviruses (LVs) were packaged and
concentrated to p24 concentrations of 3–8 3 107 pg/ml by the
Biomedicum Functional Genomics Unit, HiLife Institute (Hel-
sinki, Finland). A short hairpin (sh)RNA LV for knockdown of
ORP2wasgeneratedbyusing the shRNAcloneTRCN000154381
in pLKO.1 (Millipore-Sigma), which was used for virus
(LV-shORP2) packaging, as previously described. The shScramble
construct SHC002 (Millipore-Sigma) was used for generat-
ing a nontargeting control (LV-shScramble).
Culture and LV transduction/electroporation of
primary endothelial cells
HUVECs purchased from Lonza (Basel, Switzerland) were
grown on fibronectin gelatin–coated flasks in endothelial cell
growth medium [0.1% human epidermal growth factor, 0.1%
hydrocortisone, 0.1% gentamicin-amphotericin B, 0.4% bo-
vine brain extract, and 2% fetal bovine serum (FBS); Lonza].
For ORP2 silencing, HUVECs were transduced for 72 h with
LV-shORP2orLV-shScramble (control) using amultiplicity of
infection (MOI) of 10. For ORP2 overexpression, HUVECs
were transfected with ORP2 or control GFP plasmids with an
HUVEC Nucleofector Kit (Lonza), according to the manu-
facturer’s protocol.
RNA sequencing and pathway analysis
For RNA sequencing, samples were prepared from 4 parallel
cultures each of ORP2-KO1, ORP2-KO2 and Cas9 control
HuH7 cells using the TruSeq Stranded Total RNA Library
Prep Kit with Ribo-Zero (Illumina, San Diego, CA, USA). The
Burrows-Wheeler aligner (16) was used to align output reads
to the human reference genome (GRCh38). The FeatureCounts
program (17) was used to count mapped fragments against
genomic features defined by the Ensembl annotation file
(homo_sapiens.GRCh38.76.gtf). The genes with counts #1
in all samples were removed, and Deseq2 was used to ana-
lyze the differential gene expression (18). The Benjamini-
Hochberg test was used to control the false discovery rate.
Genes that differed significantly between ORP2-KO1 and
Cas9 control cells (fold change, log2 . 1) were selected for
analysis by the Ingenuity Pathways Analysis tool (IPA;
Qiagen, Hilden, Germany). Enrichment of the genes in the
pathways was assessed in comparison with a reference set in
the whole Ingenuity pathway knowledge base. A volcano
plot was built by using the log10-adjusted P value against a
log2 expression change of each gene in response to knock out
of ORP2 in HuH7 cells. Googlevis was used to generate a
Google interactive chart (19).
Cell migration assays
Wound-healing assays with Huh7, Cas9 control, and ORP2-
KO or ORP2-KO cells infected for 48 h with LVs over-
expressing GFP (ctrl), WT ORP2, ORP2 (mFFAT) or ORP2
(mPIP) at a MOI 10 were performed (20). In addition, cell
migration was measured with the xCelligence Real-Time
Cell Analysis system with a DP instrument (Acea Biosci-
ences, San Diego, CA, USA). ORP2-KO and Cas9 control
cells were seeded at 3 3 104 cells per chamber in the top
chambers in medium depleted of FBS (CIM-plate 16; Acea
Biosciences). The bottom electronically integrated Boyden
chambers contained basal growth medium with 10% FBS.
Cell movement from the top to the bottom chamber was
monitored for 24 h in real time by electrical impedance at
37°C, in a humidified 5% CO2 atmosphere with Radio
Technical Commission for Aeronautics (RTCA) Software
1.2 (Acea Biosciences).
Cell adhesion and proliferation assay
Cell adhesion to substratum and proliferation were mea-
sured with xCelligence Real-Time Cell Analysis systemwith
theDP instrument (Acea Biosciences). HuH7, ORP2-KO, and
Cas9 control cells were seeded at 8 3 103 cells per well on
electronic microtiter plates with noninvasive gold micro-
electrode biosensors (E-plate 16; Acea Biosciences). The
electrical impedance was monitored for 85 h in real time at
37°C in a humidified 5% CO2 atmosphere with RTCA Soft-
ware 1. Cell proliferation and adhesion were analyzed with
the same software.
Anti-HA coimmunoprecipitation and proteomics
HuH7 cells grown in 10 cm dishes were transfected with HA-
ORP2 or ORP2 expression plasmids using Lipofectamine 2000
(Thermo Fisher Scientific). After 24 h, the cells were lysed in lysis
buffer [10 mM HEPES (pH 7.6), 150 mM NaCl, 0.5 mM MgCl2,
10%glycerol, 0.5%TritonX-100, 0.5% saponin, protease inhibitor
cocktail],mixed thoroughlybyvortexingand incubatedon ice for
10 min. Unbroken cells and insoluble material were removed by
centrifugation at 20,000 g for 10 min. The obtained lysates were
mixed with 30 ml of protein G magnetic beads (Thermo Fisher
Scientific) and incubated for 30min on rotation at 4°C to remove
material unspecifically bound to the beads. After removing the
beads,30ml of anti-HAmagneticbeads (ThermoFisherScientific)
were added and incubated for 1.5 h on rotation at 4°C. The beads
werewashed3 timeswith lysis buffer and2 timeswithdeionized
H2O. Bound proteins were eluted with 100 ml of 0.1 M glycine
(pH2.0) for30minat roomtemperature. Thealkaline elutionwas
neutralized with 8 ml of 1 M Tris base (pH 9.0) before analysis of
the eluted protein with mass spectrometry of tryptic peptides at
the Meilahti Clinical Proteomic Core Facility (University of Hel-
sinki). The background proteins identified in the ORP2 sample
lacking an HA epitope tag were subtracted from the proteins
identified in the anti-HA–precipitatedHA-ORP2 sample. The list
of putative interaction partners of ORP2 was subjected to IPA
analysis as previously described.
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Pulldown and coimmunoprecipitation assays
HuH7 cells were transfected with GFP-SEPT9 or GFP-
ARHGAP12 plasmid using Lipofectamine 2000 (Thermo Fisher
Scientific) or left untransfected for the pulldown of endogenous
proteins.After 24h, the cellswerewashedand lysed in lysis buffer
[10 mM HEPES (pH 7.6), 150 mM NaCl, 0.5 mM MgCl2, 10%
glycerol, 0.5% Triton X-100, 0.5% Na-deoxycholate, protease in-
hibitor cocktail (Roche Diagnostics, Basel, Switzerland)], mixed
thoroughly and incubated on ice for 10 min. Unbroken cells and
insolublematerial were removed by centrifugation at 20,000 g for
10 min. The obtained lysates were incubated with 300 mM
GST-ORP2 or GST (produced in Sf9 cells by the BioMediTech
Protein Technologies core facility) and 20 ml glutathione-
Sepharose 4B (GE Healthcare, Waukesha, WI, USA) for 2 h at
4°C. The beads were washed 4 times with lysis buffer, resus-
pended in 30 ml Laemmli sample buffer and boiled for 5 min.
The bound proteins were detected with anti-GFP or -IQGAP1
antibodies.
The ORP2-V5 coimmunoprecipitation was performed simi-
larly: HuH7 cells were transfected with ORP2-V5 and GFP-
myosin light chain (MLC)-12 or GFP-MLC12 alone as a negative
control. The cell lysates were first incubated with 15 ml anti-HA
Magnetic Beads (Thermo Fisher Scientific) to reduce the un-
specific binding for 30minat 4°C, followedbyan incubationwith
40ml anti-V5magnetic beads (MBL) overnight at 4°C. The beads
were washed 4 times with lysis buffer, resuspended in 30 ml
Laemmli samplebuffer, andboiled for 5min. Theboundproteins
were detected with anti-GFP antibody.
Analyses of OSBPL2 expression in cancer
tissue transcriptomes
mRNA sequencing data were downloaded from 2 cohorts in-
cluding 89 samples from patients with kidney chromophobe
carcinoma. We excluded mRNAs with no counts in more than
50% of the samples in each cohort. Deseq2 was used to analyze
the differential gene expression. cBioportal (http://www.cbioportal.
org/) was used to visualize the gene amplification in tumors.
Statistical analyses
In the IPA analysis, Fisher’s exact test was used to determine the
significance of each pathway and the Benjamini–Hochberg
method was used to control for false discovery rate. Statistical
analysis of cell biologic assays was performed by using an in-
dependent, 2-tailed Student’s t test.
Other methods
Immunofluorescence staining was performed as described in
Kentala et al. (3) and Western blot analysis as in Weber-Boyvat
et al. (7).
RESULTS
Depletion of ORP2 in HuH7 cells subjected to
CRISPR-Cas9 gene editing
The endogenous OSBPL2 gene of HuH7 cells was abro-
gated by using the CRISPR-Cas9 genome editing tech-
nique with ORP2-specific gRNAs. gRNAs were targeted
to exons 4 and 5 ofOSBPL2. The CRISPR-Cas9 mutations
resulted in 14–131 nucleotide deletions in the OSBPL2
cDNA (Fig. 1A) and premature termination codons after
the amino acid residues 102–153 of ORP2. The ORP2
protein was completely absent in both KO cell lines, as
evidenced by Western blot analysis with anti-ORP2 anti-
body (Fig. 1B). Upon culture, theORP2-KO cells appeared
markedly different from the Cas9-transfected controls:
they failed to grow as even monolayers but displayed a
strong tendency to form islet-like cell clusters (Fig. 1C).
Altered mRNAs of multiple signaling
pathways suggest novel roles for ORP2 in
cellular functions beyond lipid metabolism
The next generation RNA sequencing of ORP2-KO hepa-
tocytes indicated that loss of ORP2 affects the quantity of
.2000 transcripts (Supplemental Fig. S1). The genes sen-
sitive to ORP2 depletion filtered by a minimum fold
change of 32 (a total of 579 genes; blue in the Supple-
mental Plot) were subjected to IPA, which predicted sev-
eral cellular functions and cell signaling pathways to be
dysregulated in the ORP2-KO cells (Fig. 2A). The IPA
pathways constituting the cellular function categories cel-
lularmovement, cell–cell signaling and interaction, cellular
growth and proliferation, cell death and survival and cel-
lular assembly and organization—were affected in the
ORP2-KO cells as listed in Table 2. Of note, the cellular
movement category contained the cellular migration,
invasion, and homing pathways, the cellular assembly
and organization category, several actin cytoskeleton–
associated pathways, the cell–cell signaling and interac-
tion category, and several cell junction and adhesion
pathways. The most strongly affected (according to fold
change) individual genes up- or down-regulated in the
ORP2-KO cells are listed inTable 3. Of note, themost up-
regulatedmRNAs included the RhoA effectorGPR55 (21)
and the adhesionmoleculeHEPACAM2 (22),whereas one
of the most down-regulated individual mRNAs was
VCAN encoding versican, a proteoglycan that controls cell
adhesion, migration, and proliferation (23).
OSBP/ORPs constitute a large conserved family of
proteins. In principle, their functions could be overlapping
andhence couldbe compensated for by eachother (24, 25).
We therefore specifically analyzed in ORP2-KO and con-
trol cells themRNA levels of all ORP familymembers and
also the ORP interaction partners VAP-A and -B. How-
ever, the RNA sequencing revealed no notable effect of
ORP2knockout on themRNA levels of otherOSBP/ORPs
or the VAPs (Supplemental Fig. S2). The mRNAs for all
ORPs exceptORP5, aswell asVAP-Aand -B,were present
in the ORP2-KO and Cas9 control HuH7 cells. The obser-
vation indicated that the phenotypic alterations in the
ORP2-KO cells are not significantly modified by com-
pensatory changes in the expression of other ORPs or
VAPs.
ORP2 knockout and reexpression modify the
actin cytoskeleton
Themolecular and cellular functions affected in theORP2-
KOcells, as suggestedby the IPAanalysis included several
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pathways involving the actin cytoskeleton (Table 2). We
therefore visualized F-actin in ORP2-KO andCas9 control
HuH7 cells with fluorescent phalloidin in the presence or
absence of insulin stimulation and stained the leading
edge of the cells with anti-cortactin (Fig. 2B). The ORP2-
KO cells displayed remarkable defects in the organization
of F-actin and formation of leading edge. In the ORP2-KO
cells, cortactin+ polarized lamellipodia were absent (Fig.
2C), and cortactin was instead distributed to the cell sur-
face blebs (Fig. 2D).
To further analyze the impact of ORP2 on the actin
cytoskeleton, ORP2 was overexpressed in the KO and
Cas9 cells by transfection of mCherry-ORP2 or plain
mCherry as a negative control. The overexpression of
ORP2 abolished the stress fibers and induced prominent
F-actin+ plasma membrane ruffles and cell surface pro-
trusions or filopodia-like structures in bothCas9 control and
ORP2-KO cells (Fig. 3A, B and Supplemental Fig. S3A, B).
These observations are fully consistent with the observed
mRNA alterations in multiple pathways involving the
actin cytoskeleton, cell adhesion, and migration. Of note,
overexpression of an ORP2 mutant with the conserved
PIP–binding cleft inactivated [ORP2(mPIP) (7)] failed to in-
duce morphologic changes in actin-enriched plasma mem-
brane structures in the Cas9 controls or the ORP2-KO
cells (Fig. 3C and Supplemental Fig. S3C), whereas a mu-
tant incapable of binding the VAPs [ORP2(mFFAT) (7)]
behaved similarly in thismorphologic assay to thewild-
type protein (Fig. 3D and Supplemental Fig. S3D).
To investigate whether the morphologic phenotypes
caused by ORP2 depletion or overexpression are also de-
tectable in other, noncancerous cells, we knocked down
ORP2 in primary HUVECs by using recombinant LVs or
overexpressed it by plasmid electroporation. The cells
depleted of ORP2 displayed, in the presence or absence of
insulin stimulation, a disturbance of cell F-actin mor-
phology similar to that of the ORP2-KO cells: loss of stress
fibers, a rounded morphology with an apparent defect in
spreadingon the substratum,andarobust inductionof cell
surface blebs (Supplemental Fig. S4A, B). In contrast,
overexpression of ORP2 in HUVECs induced abundant
formation of cortactin+ lamellipodia (Supplemental Fig.
S4C, D). These observations suggest that the actin pheno-
type observed inORP2-KOcells is not limited to hepatic or
cancerous cells.
The ORP2 interactome suggests an involvement
of the protein in RhoA signaling
To further elucidate the molecular mechanisms of ORP2
action, a proteomic analysis of the ORP2 interactome was
performed. HA-tagged ORP2, or a similar construct lack-
ing theHAepitope as a negative control,was expressed in
HuH7 cells, followed a pulldown by of complexes with
Figure 1. ORP2 KO in HuH7 hepatoma cells. A) The CRISPR-Cas9-derived mutations in the ORP2-KO1 and -KO2 cell lines
identiﬁed by sequencing. B) Detection of endogenous ORP2 by Western blot from native HuH7, Cas9 control, ORP2-KO1 and
ORP2-KO2 cell lysates with anti-ORP2 antibody. b-Actin is shown as the loading control. C) Light microscopy images of Cas9
control and ORP2-KO HuH7 cultures.
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anti-HA magnetic beads. Mass spectrometric analysis of
tryptic peptides identified 111 proteins that were found
specifically in theHA-ORP2complexes, butwere absent in
the negative control (Supplemental Table S1). Of note,
these proteins included the known binding partners of
ORP2 and VAP-A and -B. Several of the putative in-
teraction partners represent intramitochondrial compo-
nents, indicating that some unspecific binding may have
occurred during isolation of the complexes. Similar to the
RNA sequencing data, the potential interacting compo-
nents were subjected to IPA analysis. Strikingly, the most
significant pathway identified in the ORP2 interactome
was RhoA signaling (for overlapping genes, P = 0.006).
The 6 putative ORP2 interaction partners in the RhoA
signaling pathway were septin 9 (SEPT), ezrin (EZR),
ARHGAP, phosphatidylinositol 4-kinase a (PI4KA) and
MLC 12A and 12B (Fig. 4A, blue). Of these tentative
partners, binding of SEPT9, ARHGAP12, and MLC12 to
ORP2was validated by an independent pulldown assay.
Lysates from HuH7 cells overexpressing GFP-SEPT9
and GFP-ARHGAP12 were subjected to pulldown with
recombinant GST-ORP2 and glutathione Sepharose,
followed by Western analysis with anti-GFP. The nega-
tive GST control showed no immunoreactivity, the GST-
ORP2 pull-down contained abundant GFP-SEPT9 and
GFP-ARHGAP12 (Fig. 4B), supporting a specific in-
teraction of both proteins with ORP2. MLC12 showed a
strong binding toGST alone (data not shown); hence, the
interaction between ORP2 and GFP-MLC12 was con-
firmed by coimmunoprecipitation using ORP2-V5 and
anti-V5 magnetic beads (Fig. 4C).
Consistent with the interactome analysis, the RNA se-
quencing analysis identified 12 significantly dysregulated
mRNAs of components of the RhoA signaling pathway in
Figure 2. Molecular and cellular functions affected in the ORP2-KO cells. A) The molecular and cellular functions (RNA
sequencing analysis) signiﬁcantly affected in the ORP2-KO cells were identiﬁed. P , 0.05 after multiple test adjustment was
considered statistically signiﬁcant, and mRNAs changed at least 2-fold (579 species) were included. B) Staining of cortactin with
an antibody and F-actin with ﬂuorescent green phalloidin in Cas9 control and ORP2-KO cells grown in basal growth medium or
stimulated for 10 min with 200 nM insulin. The nuclei are visualized with DAPI. C) Quantiﬁcation of cells containing
lamellipodia from 2 independent experiments (a total of 300 cells analyzed). D) Quantiﬁcation of cells containing blebs from 2
independent experiments (a total of 300 cells analyzed). **P , 0.01, ***P , 0.001.
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the ORP2-KO cells. The up-regulated RhoA signaling
componentswere Rhotekin 1 and 2, phosphatidylinositol-
4-phosphate 5-kinase (PI4P5K), DIAPH1, and actin-
related protein 2/3 complex subunits 1A and 5 (Fig. 4A,
green), and the down-regulated ones were lysophosphati-
dic acid receptor (LPAR), profilin 1 and 2, Rho-associated
protein kinase (ROCK)-2, G-actin 1, and cofilin-2 (Fig. 4A,
red). In addition, 16 mRNAs related to Rac1 GTP-binding
protein signaling—a central pathway in the activation of the
lamellipodia formation (26, 27)—were significantly dysreg-
ulated (P = 0.03; Supplemental Fig. S5A). The interactome
analysis also suggested a physical complex between ORP2
and IQGAP1–2 (Supplemental Fig. S3A, blue), factors im-
portant in organizationof the actin cytoskeletonbyRac1and
Cdc42 signaling. By employing GST-ORP2 pulldown, an
interaction between ORP2 and endogenous IQGAP1 was
validated (Supplemental Fig. S5B).
ORP2 KO inhibits cell migration
IPA analysis of the transcriptome of ORP2-KO cells in-
dicated an alteration of the cell movement function in the
ORP2-KO cells (Table 2). Therefore, we studied the effect
of ORP2 knockout on migration of HuH7 hepatoma cells
in a wound-healing assay. Confluent monolayers of
ORP2-KO, Cas9 control, and HuH7 cells were wounded
by a small pipet tip, and thewound closure (300–400mm)
was monitored for 22 h (Fig. 5A, B), a period was
sufficient for Cas9 control cells to partly cover the
wounded area; the mean cell migration rate was de-
termined as 16.6–16.8 mm/h. Migration of the ORP2-KO
cells was significantly (by 30–49%) decelerated compared
with the control, the migration rate of these cells being
9.5–11.6 mm/h (Fig. 5B). The ability of wild-type ORP2,
ORP2(mFFAT), and ORP2(mPIP) to rescue this migration
defect was tested. The wild-type and ORP2(mFFAT)
overexpression enhanced wound closure in the ORP2-KO
cells by 74–130% and 77–125%, respectively (Fig. 5C).
However, the ORP2 PIP-binding deficient mutant (mPIP)
had no effect on the wound healing, compared with the
GFP-expressing control LV.
The effect of ORP2-KO on cell migration was further
analyzed with the xCELLigence Real-Time Cell Anal-
ysis system, by employing a transfilter migration ap-
plication. Consistently, the analysis revealed a marked
difference inmigration between theORP2-KOandCas9
control cells, the KOs. showing a 65–77% reduction in
the slopes of their migration curves (Fig. 5D, E). Treat-
ment of HuH7 or Cas9 control cells with the ROCK
antagonist Y27632, an established inhibitor of cell mo-
tility, resulted in this assay in a drastic reduction in
migration (Supplemental Fig. S6A, B).
ORP2 knockout inhibits cell adhesion
and proliferation
To investigate the putative role of ORP2 in cell adhe-
sion and proliferation, the native HuH7 cells, the Cas9
controls, and the ORP2-KO cells were monitored with
the xCELLigence Real-Time Cell Analysis system. Cell
adhesion to the substratum was measured during the
first 5 h after plating, followed by proliferation anal-
ysis for up to 85 h. Adhesion of the ORP2-KO cells to
the substratum was decelerated by 44–49% as com-
pared to the maternal HuH7 cell line and the Cas9
controls (Fig. 6A, B). Proliferation of the control cells
reached saturation in 50 h, whereas the proliferation of
ORP2-KO1 and ORP2-KO2 continued until 75 h (Fig.
6C). Analysis of the proliferation curves between 5 and
50 h revealed a 38–64% reduction in their slopes in
ORP2-KO cells, as compared to the controls, suggest-
ing a significant proliferation defect in the cells lacking
ORP2 (Fig. 6D). Treatment of HuH7 and Cas9 control
cells with the actin monomer sequestering drug
latrunculin B included as a control completely abol-
ished adhesion of the cells to the microelectrode sur-
face of the measuring chambers (Supplemental Fig.
S6C).
The observed effects of ORP2 knockout on hepatocel-
lular adhesion, migration, and proliferation prompted us
to analyze the expression of the gene inmalignant tumors
in patients by using a TCGA database. Its expression was
TABLE 2. Cellular functions related to the mRNAs affected
by ORP2-KO
Cellular function Adj. H-B P Gene (n)
Cellular movement
Cell movement 1.30 3 10213 225
Migration of cells 4.54 3 10211 194
Invasion of cells 9.08 3 10211 132
Homing of cells 3.72 3 1027 62
Chemotaxis 8.54 3 1027 60
Cell–cell signaling and interaction
Adhesion 6.16 3 1026 50
Communication of cells 9.84 3 1025 113
Intercellular communication 3.76 3 1024 26
Assembly of intercellular junctions 5.05 3 1024 13
Disruption of intercellular
junctions
6.75 3 1024 6
Formation cell-cell contact 1.39 3 1023 14
Disruption of tight junctions 1.70 3 1023 5
Signal transduction 3.26 3 1023 92
Association of plasma membrane 3.59 3 1023 3
Development of gap junctions 3.64 3 1023 9
Cellular growth and proliferation
Proliferation of cells 8.62 3 1027 223
Maturation 2.14 3 1024 5
Differentiation 6.64 3 1024 22
Cytostasis 1.11 3 1023 5
Colony formation 1.31 3 1023 57
Cell death and survival
Cell death 3.09 3 1025 283
Apoptosis 1.37 3 1024 220
Cell viability 4.11 3 1024 10
Necrosis 4.18 3 1024 234
Cell survival 3.59 3 1023 3
Cellular assembly and organization
Assembly of cells 1.54 3 1026 44
Tubulation of cells 1.12 3 1023 20
Formation of membrane rufﬂes 1.38 3 1023 6
Formation of cellular protrusions 1.56 3 1023 49
Formation of hemidesmosomes 3.59 3 1023 3
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significantly (mean fold-change, 1.66) increased in 65 solid
tumors, compared with 24 normal controls in patients
withchromophobekidneycancer (P=7.09E-15, adjustedP
= 5.81E-14). This observation indicates that elevatedORP2
expression associated with certain types of cancer could
contribute to the malignant phenotype.
DISCUSSION
In the present study, we used CRISPR-Cas9–mediated
gene editing to generate a complete KO ofOSBPL2/ORP2
in human hepatoma cells, and performed a series of anal-
yses to reach a comprehensive view of ORP2 function in
cell physiology. The viability of the ORP2-KO cells sug-
gested that ORP2 is not essential for cell survival, as is the
case for ORP4L in specific cell types (28, 29).
RNA sequencing of the ORP2-KO cells revealed
altered expression of .2000 mRNAs, 579 of which
displayed at least 2-fold expression changes. IPA of the
latter revealed alterations in the cellular function cate-
gories: cellular movement, cell–cell signaling and in-
teraction, cellular development, cellular function and
maintenance, cellular growth and proliferation, cell mor-
phology, and cell death and survival. Many pathways in
these categories involved the actin cytoskeleton, cell mi-
gration, adhesion or proliferation. Analysis of the ORP2
interactome uncovered 109 putative new interaction part-
ners, IPA analysis ofwhich revealedRhoA signaling as the
most significantORP2-associatedpathway.Of theputative
partners of ORP2 in RhoA signaling, SEPT9, MLC12, and
ARHGAP12, as well as IQGAP1, were validated by in-
dependent pulldown or coimmunoprecipitation assays.
Consistently, loss of ORP2 resulted in an abnormal F-actin
morphology characterized by impaired capacity to form
cortactin+ lamellipodia. Further functional analyses
demonstrated that lack of ORP2 resulted in a migra-
tion defect and reduced rates of cell adhesion and
proliferation.
ORP2 has been investigated in the context of cellular
cholesterol and TG metabolism (4, 5, 30, 31), as well as in
steroid hormone biogenesis by adrenocortical cells (8).
Moreover, ORP2 has shown to localize, together with its
ER membrane anchor VAP-A, at ER–LD contacts (7). Li
et al. (9), in adrenocortical cells, found a physical in-
teraction of ORP2 with DIAPH1, a Rho GTPase effector
protein that coordinates cellular dynamics by regulating
actin microfilament and microtubule function. The re-
ported ORP2–DIAPH1 interaction implicated a close link
between ORP2 function and the actin cytoskeleton. Con-
nections with cytoskeletal functions have been suggested
also for other members of the ORP family: ORP10 was
shown to associatewithmicrotubules and tomodulate the
secretion of b-lipoprotein by hepatocytes (32, 33). ORP1L
was demonstrated to act as a sterol sensor in a pro-
tein complex that controls ER–late endosome contacts,
dynein–dynactin recruitment onto late endosomes, and
the microtubule-dependent motility and fusion of the
TABLE 3. The most strongly affected individual mRNAs in ORP2-KO cells
Protein coding
Log expression
value Adj. H-B P Cellular function Reference
Up-regulated genes
TXNIP Thioredoxin-interacting protein 3.70 5.9 3 102230 Thioredoxin activity, metabolism 69, 70
GPR55 GPCR 55 3.30 2.9 3 10267 RhoA effector 21
NELL2 Neural EGFL like 2 2.65 2.9 3 10235 Neural cell growth 71
HEPACAM2 Hepatocyte cell adhesion molecule
family member 2
2.63 9.4 3 10295 Adhesion 22
VEPH1 Ventricular zone expressed PH
domain containing 1
2.50 8.0 3 10235 Akt regulation 72
HEPH Hephaestin 2.43 1.6 3 10227 Ferroxidase 73
LGALS3BP Galectin-3–binding protein 2.42 1.4 3 102218 Cell–cell and cell–matrix association 74
CA4 Carbonic anhydrase 4 2.29 1.0 3 102141 Catalysis of CO2 reversible hydration 75
C4BPB Complement component 4 binding
protein b
2.27 8.9 3 102105 Complement activation 76
ANXA3 Annexin A3 2.04 1.8 3 10287 Phospholipid binding 77
Down-regulated genes
EDIL3 EGF like repeats and discoidin
domains 3
22.80 4.2 3 10229 Integrin binding 78
EMC10 ER membrane protein complex
subunit 10
22.74 3.8 3 10227 ER-associated degradation 79
NPTX2 Neuronal pentraxin 2 2.71 2.5 3 10229 Excitatory synapse formation 80
MYH4 Myosin, heavy chain 4 22.53 2.8 3 102196 Actin network disassembly, cell
motility
81
PLG Plasminogen/plasmin 22.40 4.8 3 10270 Serine protease 82
VCAN Versican 22.22 3.7 3 10233 Antiadhesion molecule 23
ARG1 Arginase 1 22.07 2.6 3 10250 Arginine hydrolysis 83
SLC16A3 Monocarboxylate transporter 4 22.06 1.5 3 102170 PM monocarboxylate transporter 84
MBL2 Mannose-binding lectin 2 21.98 3.5 3 10239 Complement activation 85
EPB41L3 Erythrocyte membrane protein band
4.1 like 3
21.96 9.5 310214 Tumor suppressor 86
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endosomes (34, 35). Moreover, ORP3 was shown to
regulate the activity of the small GTPase R-Ras, a key
controller of cell adhesion and migration, and genetic
manipulation of this ORP induced distinct alterations
of F-actin organization (36, 37). Finally, ORP4 was
discovered to associate with vimentin intermediate
filaments and have a capacity to modify their organi-
zation (38, 39). Of note, Dong et al. (40) recently dem-
onstrated that ER–endosome contacts, generated by
OSBP and VAPs, regulate PI4P levels on the endo-
somes, thus controlling the nucleation of actin on these
organelles.
The present RNA sequencing, ORP2 interactome, and
morphologic analyses accumulate new evidence for a
close link between the ORPs and cytoskeletal regulation.
The knockout of ORP2 disrupted the F-actin organization
of HuH7 cell and hampered cell adhesion, migration, and
spreading of polarized lamellipodia. Instead of lamelli-
podia, the KO cells formed cell surface blebs, which may
arise as a result of defective F-actin–plasma membrane
interactions (41, 42). The lamellipodia and migration de-
fects in theORP2-KO cells provide a plausible explanation
for the growth mode of the KO cells, as the defects may
result inan inabilityof thedividingcells todetach fromone
another and migrate, thus forming islet-like cell patches
upon culture. The observations outlined above indicate
that ORP2 physically interacts with actin-regulatory pro-
teinmachineries, but its genetic depletion also impacts the
mRNA expression of such components. The physical in-
teractions of ORP2 with actin regulators may not be me-
diated by ORP2–VAP complexes at the ER–LD contact
sites (7), but more likely reflect ORP2 function at other
subcellular locations: Laitinen et al. (4) showed by cell
fractionation that,50% of the endogenous ORP2 in Chi-
nese hamster ovary cells was membrane-associated, and
most remained in the soluble fraction. Moreover, treat-
ment of cells with the high-affinity ligand of ORP2, 22(R)
OHC, detached ORP2 from the LD, inducing its re-
distribution to the plasma membrane and a diffuse
cytosolic-like localization (5). Likewise, ORP2–VAP-A
complexes redistributed upon addition of this oxysterol
away from the ER–LD junctions (3). Interactions with
membranePIPs (30) andwith actin regulators couldplay a
role in the targeting of ORP2 to the cell cortex, where key
regulation of dynamic actin polymerization, branching,
and depolymerization takes place (43–45). On the other
hand, several ORP familymembers have been reported to
mediate countercurrent lipid transport employing PI4P
transfer to drive the transport of sterols or phosphati-
dylserines (46–49). Overexpression of a mutant ORP2
Figure 3. Reexpression of ORP2 in the KO
cells modiﬁes the actin cytoskeleton. A, B)
Staining of F-actin with ﬂuorescent green
phalloidin in Cas9 control (A) and ORP2-KO
(B) cells transfected with plain mCherry as a
control or mCherry-ORP2. C) ORP2-KO cells
transfected with mCherry-ORP2 (mPIP) with the
PIP-binding cleft inactivated. D) ORP2-KO cells
transfected with mCherry-ORP2 (mFFAT) in-
capable of binding to VAPs.
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(mPIP) with the PIP-binding cleft inactivated failed to in-
duce plasma membrane ruffles and cell surface protru-
sions like thewild-type protein. Likewise, thismutantwas
unable to rescue the migration defect of ORP2-KO cells.
These observations suggest that the actin regulatory and
cell migration functions of ORP2 may involve a lipid
countertransport activity in which PIPs represent one of
the substrates. Paradoxically, however, these activities of
ORP2 do not appear to require its association with the
VAPs, because ORP2 (mFFAT), incapable of VAP in-
teraction, behaved similarly to thewild-type protein in the
morphologic and migration assays.
ThesmallGTPaseRhoAisamajor regulatorof cell shape,
polarity, and locomotion via actin polymerization, actomy-
osin contractility, cell adhesion, and microtubule dynamics
(50). Signaling pathways regulated by RhoA connect PM
receptors to the formation of focal adhesions and a sub-
sequent activation of actin stress fibers (51). Among the
components mediating the stimulation of actin polymeri-
zation by RhoA are the diaphanous-related formins, in-
cluding DIAPH1 (9). ROCK induces actomyosin-based
contractility and controls the activity of myosins and
other actin-binding proteins, to facilitate the detachment
and migration of cells. Moreover, RhoA plays a pivotal
role in cell cycle progression, through regulation of the
expression of cyclinD1 (52, 53) and the cyclin-dependent
kinase inhibitor p27Kip1 (54, 55).
Both the RNA sequencing of ORP2-KO cells and the
ORP2 interactome analysis supported the notion that
ORP2 is physically and functionally linked to the RhoA
signaling pathway. These observations bear marked re-
semblance to observations in yeast: The yeast ORPs, the
Osh proteins, are required for polarized exocytosis by
maintaining the proper localization of septins, the Rho
GTPases Cdc42p and Rho1p, aswell as of the RabGTPase
Sec4p (56). Moreover, the yeast ORP Osh4p was found to
reside on exocytic vesicles and to formphysical complexes
withCdc42p,Rho1p, Sec4p, and the exocyst subunit Sec6p
(57). Physical, albeit not necessarily direct, interaction of
ORP2 with the RhoA signaling components Septin 9,
MLC12, and ARHGAP12 was validated. ARHGAP12
belongs to the RhoGAP family of GTPase-activating
Figure 4. ORP2 interactome and ORP2-KO transcriptome analysis connects ORP2 to RhoA signaling. A) Endogenous ORP2
interaction partners were coprecipitated with anti-HA magnetic beads from HA-ORP2 overexpressing HuH7 cells and identiﬁed
by mass spectrometry. The ORP2 interactome was analyzed and the results indicated that RhoA signaling was a signiﬁcantly
affected canonical pathway. The putative interaction partners are shown in blue. The RhoA signaling components dysregulated
in the transcriptome of ORP2-KO cells are shown in green (for up-regulation) and red (for down-regulation). Most abbreviations
are deﬁned on the title page. The remaining ones follow: SEPT, septin; EZR, ezrin; PI4KA, phosphatidylinositol 4-kinase a;
PI4P5K, phosphatidylinositol-4-phosphate 5-kinase; LPAR, lysophosphatidic acid receptor; B) Pulldown assays verifying the
interaction of ORP2 with ARHGAP12 and SEPT9. HuH7 cells expressing GFP-ARHGAP12 and GFP-SEPT9 constructs were lysed
and subjected to GST-ORP2 pulldown. Cell lysates (L) and pulldowns (PD) were analyzed by Western blot analysis with anti-GFP
antibody. Plain GST was used as a negative control. C) Coimmunoprecipitation assay verifying the interaction of ORP2 with
MLC12. HuH7 cells expressing GFP-MLC12 and V5-ORP2 or, as a negative control, only the GFP-MLC12 construct, were lysed
and subjected to V5-immunoprecipitation. Cell lysates (L) and coimmunoprecipitation (PD) were analyzed by Western blot
analysis with anti-GFP antibody.
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proteins, which regulate the activity of Cdc42, Rac1, and
RhoARhoGTPases (58, 59). Septin 9 is a filament-forming
GTPase suggested to act as a negative upstream regulator
of RhoA, with functions in cytokinesis and cell cycle con-
trol as a possible tumor suppressor (60–62). Furthermore,
MLC phosphorylation controls actin–myosin interaction
Figure 5. ORP2-KO impairs the migration of HuH7 cells. A) Wound-healing assay with HuH7, Cas9 control, and ORP2-KO1 and -KO2
cells. Representative images from the 0 to 22 h time points are shown. B) Quantiﬁcation of the mean cell migration rate from 8 repeats
of the experiment is shown. C) Quantiﬁcation of the mean cell migration rate from a duplicate wound-healing experiment of ORP2-
KO cells infected with a empty GFP-expressing control LV (ctrl) or a LV overexpressing ORP2 wild-type (WT), or ORP2 incapable of
binding to VAPs (mFFAT) or ORP2 with the PIP-binding cleft inactivated (mPIP). Western blots with anti-ORP2 verifying expression of
the LV constructs, with actin as a loading control, are shown on the right. D) Migration of Cas9 control and ORP2-KO1 and -2 cells
analyzed in 4 replicate assays. E) Quantiﬁcation of the slope of the migration curve between 1 and 16 h, from 2 independent
experiments, each performed in quadruplicate. Data are means 6 SD. *P , 0.05, **P , 0.01, ***P , 0.001.
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and smooth muscle contraction, which is regulated by
RhoA downstream effector ROCK (63). Most of the RhoA
pathway components were down-regulated in the gene
expression analysis, suggesting that loss of ORP2 damp-
ens the signaling, or in other words, that the endogenous
ORP2 acts to promote the RhoA signaling. Themigration,
adhesion, andproliferation assays all revealeddampening
of these processes in the ORP2-KO cells, fully consistent
with a reduced RhoA pathway activity. In addition to the
RhoA pathway components, the RNA sequencing and
interactome analyses identified several components of
other actin-associated IPA pathways; from these proteins,
interaction with endogenous cellular IQGAP1 was vali-
dated. IQGAP1 is a scaffold that integrates signals regu-
lating cell adhesion, actin cytoskeleton, and the cell cycle
(64). The significant impacts of ORP2 knockdown on he-
patocellular migration and proliferation bring up the idea
that enhanced ORP2 expression, such as that observed in
chromophore kidney cancer,may contribute tomalignant
cell phenotypes.
We find it likely that the present observations relate to
the localization of ORP2 in the stereocilia of cochlear cells
and the documented role of its mutations in autosomal
dominant nonsyndromic hearing loss (11, 12). Our data
suggest that the function of ORP2 involves regulation of
F-actin,which forms a key structural element of stereocilia
(65). Consistently, mutations in DIAPH1, a physical in-
teraction partner of ORP2 and a regulator of actin dy-
namics,were identifiedasacauseof similarnonsyndromic
hearing loss (66–68).
To summarize, the present results indicate novel func-
tions of ORP2 beyond lipid metabolism, as a regulator of
the actin cytoskeleton with impacts on hepatocellular mi-
gration, adhesion, and proliferation.
Figure 6. ORP2-KO impairs the adhesion and proliferation of HuH7 cells. A) Adhesion of native HuH7, Cas9 control, and ORP2-
KO1 and -2 cells analyzed with in 4 replicate assays. B) Quantiﬁcation of the slope of the cell adhesion curve between 1 and 5 h,
from 2 independent experiments, each performed in quadruplicate. C) Proliferation of native HuH7, Cas9 control, and ORP2-
KO1 and -2 cells analyzed in 4 replicate experiments. D) Quantiﬁcation of the slope of the proliferation curve between 5 and
50 h, from 2 independent experiments each performed in quadruplicate. Data are means 6 SD. ***P , 0.001.
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